Key result
Automated Blood Conditioning platform maintains target oxygen saturation across ~99% of steady-state samples.
Why the study?
Current methodologies for in vitro evaluation of artificial organs and ECLS systems require large volumes of blood, extensive manual labor, and lengthy conditioning periods.
Does an Automated Blood Conditioning (ABC) platform rapidly condition and continuously maintain target inlet blood conditions for in vitro artificial lung and ECLS system evaluation?
Does an Automated Blood Conditioning (ABC) platform rapidly condition and continuously maintain target inlet blood conditions for in vitro artificial lung and ECLS system evaluation?
The Automated Blood Conditioning platform enables rapid, precise, and automated maintenance of target blood parameters for up to 10 hours in vitro using only 1.1 L of blood, improving efficiency for ECLS and artificial lung testing.
Answers are grounded in this paper and cite their sources.
Supports automated blood conditioning for standardized artificial lung bench testing; leaves open in vivo validation and clinical translation.
Artificial organs and Extracorporeal Life Support (ECLS) systems require extensive in vitro evaluation before in vivo preclinical and human trials are conducted. Current methodologies require large volumes of blood, extensive manual labor, and lengthy conditioning periods. To remedy these shortcomings, an “Automated Blood Conditioning (ABC) platform” was developed. Automated blood conditioning is a closed-loop perfusion circuit, control algorithm, and protocol that rapidly conditions and continuously maintains blood conditions for artificial lung and ECLS system evaluation, permitting efficient testing of ECLS devices with minimal blood volume, and showing potential for long-term use. The platform includes a hemoconcentrator, Terumo CDI 500 blood parameter monitor (CDI 500), custom gas mixer, and computer-based controller. A proportional-integral-derivative (PID) algorithm automatically adjusts sweep gas concentrations to maintain target inlet blood conditions despite disturbances from the test device. From arterial conditions, oxygen saturation (sO 2 %) settles at the venous target of 65% in approximately 5 minutes, and partial pressure of carbon dioxide (pCO 2 ) at 45 mm Hg in approximately 6 minutes. In this feasibility study, four independent runs on separate blood batches (48.5 hours) held sO 2 % within ±5% of target for 99.2% of steady-state samples (error 1.2%); the primary evaluation run maintained physiologic conditions for its first 10 closed-loop hours, and device flows up to 0.6 L/min using 1.1 L of blood.
No takes yet. Share an insight, caveat, or question.
Beardell et al. (2026) studied Artificial lung and Extracorporeal Life Support (ECLS) system in vitro evaluation (n=4). Automated Blood Conditioning (ABC) platform was evaluated on Steady-state samples holding oxygen saturation (sO2%) within ±5% of target. The Automated Blood Conditioning platform held oxygen saturation within ±5% of the venous target for 99.2% of steady-state samples across 48.5 hours of in vitro testing.
Synapse has enriched 10 related papers. Consider them for comparative context: